-
COVID-19 + flu coinfections? 7 things to know
As the U.S. enters its regular flu season, there's still a lot unknown about coinfection of flu and SARS-CoV-2 viruses. -
Antidepressants may lower COVID-19 death risk, study suggests
People taking certain antidepressants, particularly fluoxetine, may have a lower death risk from COVID-19, according to research published Nov. 15 in JAMA Network Open. -
Overcoming Barriers to Using Risk Assessment Tools in Pulmonary Arterial Hypertension
Medical understanding of pulmonary arterial hypertension (PAH) has come a long way in the last 20 years.1,2 Today, the medical community has a much clearer picture of the pathophysiology of this disease.1 -
Sepsis-related deaths highest among older people, CDC finds
In 2019, three-fourths of the country's 201,092 sepsis-related deaths were among people aged 65 and older, according to a report from the CDC's National Center for Health Statistics published Nov. 10. -
17 systems recognized for patient safety across Pennsylvania
The Hospital Association of Pennsylvania announced Nov. 10 17 systems across the state as 2021 Hospital Association of Pennsylvania Excellence in Patient Safety Program honorees. -
Sleep disorders tied to worse COVID-19 outcomes, Cleveland Clinic study finds
People with certain sleep disorders face a 31 percent increased risk for hospitalization and mortality from COVID-19, according to research published Nov. 10 in JAMA Network Open. -
What data from 20 systems shows about breakthrough infections
People with diabetes, chronic lung disease or chronic kidney disease may be at increased risk for breakthrough infections compared to the general population, according to Nov. 9 research from the health system-led data analytics startup Truveta. -
US lacks uniform rules for COVID-19-positive organ donors
The U.S. lacks a universally accepted set of recommendations for when organs can safely be recovered from COVID-19-positive donors, The New York Times reported Nov. 8. -
200+ hospitals participating in new federal program to boost maternal, infant health
New HHS program 1st to link data from mothers and newborns to improve outcomes, reduce disparities -
Researchers identify gene tied to increased risk of respiratory failure from COVID-19
People with a specific version of a gene known as LTZFL1 may be at increased risk of respiratory failure from COVID-19, according to research published Nov. 4 in Nature. -
Men are more likely to die of COVID-19: 4 factors that may explain why
A solid foundation of research has shown that men are more likely to die of COVID-19 than women, but the reason for this disparity is still unknown. -
NIH to follow 1,500 pregnant patients to study long-term effects of COVID-19
The National Institutes of Health will follow up to 1,500 pregnant COVID-19 patients and their offspring for four years to study the potential long-term effects of the infection. -
New York hospital first to implement CLEAR's Health Pass to improve health screenings
New York-based Hospital for Special Surgery is the first hospital in the U.S. to implement CLEAR's Health Pass, a mobile experience that verifies proof of vaccination, to improve health screenings following a successful pilot program, according to a Nov. 3 press release. -
COVID-19 respiratory symptoms more prevalent among overweight, obese individuals, study finds
Overweight or obese adolescents and adults experience more respiratory symptoms from COVID-19 despite similar viral loads compared with normal-weight individuals, according to a study published Oct. 19 in Influenza and Other Respiratory Viruses. -
COVID-19 vaccination offers more protection than infections, CDC study finds
While a previous bout with COVID-19 offers some immune protection from a subsequent infection, the protection from vaccination is stronger, the CDC's Oct. 29 Morbidity and Mortality Weekly Report suggests. -
Coronavirus can infect inner ear, study finds
Certain types of cells in the inner ear produce the proteins needed for SARS-CoV-2 entry — a potential explanation for why some COVID-19 patients experience audiovestibular symptoms, according to research published Oct. 29 in Communications Medicine. -
2nd COVID-19 vaccine dose critical for pregnant women, study suggests
Pregnant and breastfeeding women generate a weaker immune response after their first COVID-19 dose relative to nonpregnant women of similar ages, according to a recent study published in Science Translational Medicine. -
Nearly all severely allergic people tolerate COVID-19 vaccines, study finds
While individuals with severe allergies reported more reactions after receiving a COVID-19 mRNA vaccine than those without allergies, nearly all were able to safely complete the series, according to an Oct. 27 study in JAMA Network Open. -
Physician viewpoint: Pandemic spotlights cracks in US chronic care system
The COVID-19 pandemic revealed significant flaws in the U.S. healthcare system's approach to managing chronic diseases that must be addressed, Marshall Chin, MD, an internist and professor at UChicago Medicine, wrote in an Oct. 23 op-ed published in The New England Journal of Medicine. -
Millions with mood disorders now eligible for boosters
The inclusion of mood disorders in the CDC's recent update to its list of conditions tied to a higher risk of severe COVID-19 makes millions of people with such conditions now eligible for booster vaccine doses, The Washington Post reported Oct. 27.
Page 46 of 50